Edward Mendell & Co.
Records under this name other than patents Edward Mendell & Co. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,245,356 | Sustained release heterodisperse hydrogel systems-amorphous drugs Term ended Term ended Feb 4, 2020 · From the USPTO record | Term ended | Term ended Feb 4, 2020 | From the USPTO record |
| US 6,217,909 | Pharmaceutical excipient having improved compressibility Term ended Term ended Nov 12, 2019 · From the USPTO record | Term ended | Term ended Nov 12, 2019 | From the USPTO record |
| US 6,245,355 | Sustained release matrix for high-dose insoluble drugs Term ended Term ended Oct 19, 2019 · From the USPTO record | Term ended | Term ended Oct 19, 2019 | From the USPTO record |
| US 6,136,343 | Sustained release heterodisperse hydrogel systems for insoluble drugs Term ended Term ended Dec 8, 2018 · From the USPTO record | Term ended | Term ended Dec 8, 2018 | From the USPTO record |
| US 6,039,980 | Sustained release excipient Term ended Term ended Jul 29, 2018 · From the USPTO record | Term ended | Term ended Jul 29, 2018 | From the USPTO record |
| US 6,048,548 | Sustained release heterodisperse hydrogel systems-amorphous drugs Term ended Term ended Jun 29, 2018 · From the USPTO record | Term ended | Term ended Jun 29, 2018 | From the USPTO record |
| US 6,106,865 | Pharmaceutical excipient having improved compressibility Term ended Term ended Mar 10, 2018 · From the USPTO record | Term ended | Term ended Mar 10, 2018 | From the USPTO record |
| US 6,103,219 | Pharmaceutical excipient having improved compressibility Term ended Term ended Dec 17, 2017 · From the USPTO record | Term ended | Term ended Dec 17, 2017 | From the USPTO record |
| US 6,056,977 | Once-a-day controlled release sulfonylurea formulation Term ended Term ended Oct 15, 2017 · From the USPTO record | Term ended | Term ended Oct 15, 2017 | From the USPTO record |
| US 6,093,420 | Sustained release matrix for high-dose insoluble drugs Term ended Term ended Jul 8, 2017 · From the USPTO record | Term ended | Term ended Jul 8, 2017 | From the USPTO record |